LOG IN
SIGN UP
MARKET
MMSI
MMSI
Merit Med Sys Inc
NASDAQ
Real-time Quotes | Nasdaq Last Sale
60.79
+1.70
+2.88%
After Hours: 60.79 0 0.00% 16:01 05/26 EDT
OPEN
59.61
PREV CLOSE
59.09
HIGH
61.47
LOW
57.70
VOLUME
309.49K
TURNOVER
0
52 WEEK HIGH
73.85
52 WEEK LOW
51.66
MARKET CAP
3.45B
P/E (TTM)
72.82
1D
5D
1M
3M
1Y
5Y
Those who invested in Merit Medical Systems (NASDAQ:MMSI) five years ago are up 69%
Merit Medical Systems, Inc. ( NASDAQ:MMSI ) shareholders have seen the share price descend 14% over the month. But at...
Simply Wall St. · 4d ago
BRIEF-Starboard Value LP Takes Share Stake In Kohls and Humana
reuters.com · 05/13 21:44
If You Like EPS Growth Then Check Out Merit Medical Systems (NASDAQ:MMSI) Before It's Too Late
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Simply Wall St. · 05/06 16:28
Merit Medical (MMSI) Q1 Earnings Beat, FY22 View Unchanged
Merit Medical (MMSI), in the first quarter, benefits from revenue growth in both its segments and from all of the product categories within its Cardiovascular unit.
Zacks · 04/28 16:19
--Barrington Lowers Merit Medical Systems Price Target to $78 From $82, Maintains Outperform Rating
MT Newswires · 04/28 11:55
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of 12.77% and 4.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 04/27 21:35
Merit Medical Systems Q1 Adj. EPS $0.53 Beats $0.46 Estimate, Sales $275.40M Beat $264.69M Estimate
Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.46 by 15.22 percent. This is a 1.92 percent increase over earnings of $0.52 per share
Benzinga · 04/27 20:39
Merit Medical Systems Non-GAAP EPS of $0.53 beats by $0.06, revenue of $275.4M beats by $11.08M
Merit Medical Systems press release (NASDAQ:MMSI): Q1 Non-GAAP EPS of $0.53 beats by $0.06. Revenue of $275.4M (+10.6% Y/Y) beats by $11.08M. 2022 Financial Guidance" Expects Net revenue in the
Seekingalpha · 04/27 20:22
No Data
Learn about the latest financial forecast of MMSI. Analyze the recent business situations of Merit Med Sys Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 8 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
50.00%Strong Buy
37.50%Buy
12.50%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MMSI stock price target is 76.00 with a high estimate of 88.00 and a low estimate of 72.00.
Current 60.79
EPS
Actual
Estimate
0.180.350.530.71
Institutional Holdings
Institutions: 401
Institutional Holdings: 69.77M
% Owned: 123.09%
Shares Outstanding: 56.68M
TypeInstitutionsShares
Increased
104
2.93M
New
46
1.11M
Decreased
79
3.87M
Sold Out
28
555.62K
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.54%
Healthcare Equipment & Supplies
+0.56%
Key Executives
Chairman/Director/President/Chief Executive Officer
Fred Lampropoulos
Chief Financial Officer/Treasurer
Raul Parra
Corporate Executive
Joseph Wright
Chief Operating Officer
Neil Peterson
Chief Human Resource Officer
Michel Voigt
Other
Robert Fredericks
Secretary
Brian Lloyd
Lead Director/Independent Director
F. Ann Millner
Independent Director
A. Scott Anderson
Independent Director
Jill Anderson
Independent Director
Lonny Carpenter
Independent Director
Stephen Evans
Independent Director
David Floyd
Independent Director
Thomas Gunderson
Independent Director
James Hogan
Independent Director
Lynne Ward
No Data
No Data
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures and markets medical products for interventional and diagnostic procedures. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.
Webull offers kinds of Merit Medical Systems, Inc. stock information, including NASDAQ:MMSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MMSI stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading MMSI stock methods without spending real money on the virtual paper trading platform.